← Browse by Condition
Medical Condition

violence

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for violence sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — violence Clinical Trials

How many clinical trials are currently recruiting for violence?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for violence, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for violence?
violence research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a violence clinical trial?
Eligibility criteria for violence trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
Virginia Commonwealth University 1 trial
University of Notre Dame 1 trial
University of Michigan 1 trial
Johns Hopkins University 1 trial

Recruiting Clinical Trials

NCT04813185
Recruiting
Preventing Retaliatory Gun Violence in Violently Injured Adults
Enrollment
616 pts
Location
United States
Sponsor
Virginia Commonwealth Universi...
View Trial →
NCT07667738 Phase 2
Recruiting
Evaluating the Effectiveness of the Common Elements Treatment Approach (CETA) in Peru: Mechanisms of Individual and Intergenerational Change
Enrollment
600 pts
Location
Peru
Sponsor
University of Notre Dame
View Trial →
NCT05887973
Recruiting
Addressing Root Causes for Gun Violence Prevention (ARC-GVP)
Enrollment
250 pts
Location
United States
Sponsor
University of Michigan
View Trial →
NCT07227337
Recruiting
Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study
Enrollment
676 pts
Location
United States
Sponsor
Johns Hopkins University
View Trial →

Related Conditions

depression (2) parenting (1) poverty (1) mental health (1) posttraumatic stress (1) economic factors (1) child psychology (1) adolescent (1) firearm injury (1) aggression (1) post traumatic stress disorder (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology